FORWARD FEATURES CALENDAR

Share this article?

NEWSLETTER

Like this article?

Sign up to our free newsletter

Riverside’s latest add-on to Alter Pharma expands product and service portfolio

Alter Pharma, a Belgian pharmaceutical group focused on the distribution of medicines and the development and manufacturing of generic drugs commercialized worldwide, and a portfolio company of The Riverside Company, has invested in EcoPharmaSupply (EPS). Also a Belgian pharmaceutical services and product company, EPS is a distributor and partner of choice of several pharmaceutical brands on the Benelux market, including prescription drugs, medical devices, OTC pharmaceuticals and consumer health products.

Riverside acquired a majority stake in Alter Pharma in December 2017. Under Riverside’s ownership, the company has successfully launched several injectable products on the US market, invested in a promising pipeline of products under development, attracted and retained a talented group of individuals and professionalized its operations to become best-in-class.

The add-on acquisition of EPS ties perfectly with Alter Pharma’s purpose of making affordable medicines available to all. 

Like this article? Sign up to our free newsletter

FEATURED

MOST RECENT

FURTHER READING